UniSa - IRIS Institutional Research Information System

ALTIERI, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.679
AS - Asia 4.139
EU - Europa 1.598
SA - Sud America 124
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
AN - Antartide 1
Totale 10.580
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.544
HK - Hong Kong 2.790
SG - Singapore 532
CN - Cina 528
UA - Ucraina 399
DE - Germania 388
RU - Federazione Russa 330
IT - Italia 178
CA - Canada 108
VN - Vietnam 108
BR - Brasile 104
IE - Irlanda 96
KR - Corea 95
FI - Finlandia 89
GB - Regno Unito 28
IN - India 27
SE - Svezia 24
MX - Messico 18
TR - Turchia 15
NL - Olanda 14
JP - Giappone 12
EU - Europa 10
PL - Polonia 10
ZA - Sudafrica 10
ES - Italia 8
BD - Bangladesh 7
FR - Francia 6
AR - Argentina 5
CO - Colombia 5
GR - Grecia 4
AT - Austria 3
AU - Australia 3
BG - Bulgaria 3
EC - Ecuador 3
JO - Giordania 3
KE - Kenya 3
LT - Lituania 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
JM - Giamaica 2
NP - Nepal 2
PK - Pakistan 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
BZ - Belize 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
GH - Ghana 1
GM - Gambi 1
HU - Ungheria 1
IQ - Iraq 1
IR - Iran 1
KG - Kirghizistan 1
KI - Kiribati 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
MQ - Martinica 1
MT - Malta 1
MY - Malesia 1
NE - Niger 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TG - Togo 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
YE - Yemen 1
Totale 10.580
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.787
Ann Arbor 817
Jacksonville 476
Chandler 406
Princeton 333
Singapore 240
Dallas 208
Ashburn 122
Wilmington 101
Dublin 96
Ottawa 92
Andover 90
Nanjing 86
Nürnberg 86
Boardman 76
Dong Ket 76
Woodbridge 76
Beijing 68
Pellezzano 54
Houston 40
Fairfield 39
Jinan 36
Changsha 35
Shenyang 35
Munich 34
Hebei 24
Jiaxing 24
Tianjin 24
Los Angeles 22
Nanchang 20
Naples 20
New York 19
São Paulo 18
Pune 17
Zhengzhou 17
Seattle 16
Brooklyn 15
Ho Chi Minh City 15
Norwalk 15
San Francisco 15
Salerno 14
Moscow 13
Redwood City 13
Izmir 11
Guangzhou 10
Atlanta 9
Chicago 9
Columbus 9
Hangzhou 9
San Diego 9
Vietri Sul Mare 9
Warsaw 9
Boston 8
Cambridge 8
Düsseldorf 8
Johannesburg 8
Nuremberg 8
Phoenix 8
Hanoi 7
Mexico City 7
Montreal 7
Ningbo 7
The Dalles 7
Tokyo 7
Turku 7
Chennai 6
Mountain View 6
Stockholm 6
Taiyuan 6
Taizhou 6
Amsterdam 5
London 5
Mestre 5
Rio de Janeiro 5
Santa Clara 5
Charlotte 4
City of London 4
Denver 4
Edinburgh 4
Fort Worth 4
Guardia Sanframondi 4
Lappeenranta 4
Madrid 4
Manchester 4
Orem 4
Prineville 4
Toronto 4
Amman 3
Council Bluffs 3
Falls Church 3
Fenton 3
Haikou 3
Lanzhou 3
Marano Di Napoli 3
Nairobi 3
Paris 3
Poplar 3
Salvador 3
Sydney 3
Tashkent 3
Totale 7.153
Salva come PNG Salva come JPEG
Nome #
Modulation of BAG3 expression in human normal urothelial cells by Diuron 1.041
Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: Prognostic indicators of disease-specific survival 868
Amelanotic Malignant Melanoma of the Male Urethra: A Potential Diagnostic Pitfall 510
Ultrasonographic evaluation of urethrovesical junction mobility: correlation with type of delivery and stress urinary incontinence 400
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 342
Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol 342
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 340
A preoperative clinical prognostic model for non-metastatic renal cell carcinoma 219
Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma 207
Are Referral Centers for Non-Muscle-Invasive Bladder Cancer Compliant to EAU Guidelines? A Report from the Vesical Antiblastic Therapy Italian Study 150
Choroidal evaluation in patients under alpha-lytic therapy 122
A serum metabolomic signature for the detection and grading of bladder cancer 113
A randomised study evaluating maintenance schedule in early adjuvant chemotherapy for intermediate risk non-muscle-invasive bladder cancer 111
A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer 110
The best prostate biopsy sampling system—fusion and systematic biopsy: A single center experience 107
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms 106
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers. 103
Concordance and Clinical Significance of Uncommon Variants of Bladder Urothelial Carcinoma in Transurethral Resection and Radical Cystectomy Specimens 102
Can pT2 classification for renal cell carcinoma be improved? An international multicenter experience? 102
Role of Polysomy 17 in Transitional Cell Carcinoma of the Bladder: Immunohistochemical Study of HER2/neu Expression and FISH Analysis of c-erbB-2 Gene and Chromosome 17 101
Proposal for revision of the TNM classification system for renal cell carcinoma 100
Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients 98
Prognostic relevance of tumour size in T3a renal cell carcinoma: A multicentre experience 98
Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas 98
A randomized trial comparing tamoxifen therapy vs. Tamoxifen prophylaxis in bicalutamide-induced gynecomastia 95
Altered expression of specific genes in the HOX network is associated with human bladder transitional cell carcinomas 92
Calcitonin-producing well-differentiated neuroendocrine carcinoma (carcinoid tumor) of the urinary bladder: case report 91
A nomogram predicting renal cell carcinoma-specific survival in patients with nodal metastases is more accurate than any individual variable 89
PTPD1 Supports Receptor Stability and Mitogenic Signaling in Bladder Cancer Cells 89
Cigarette smoking status at diagnosis and recurrence in intermediate-risk non-muscle-invasive bladder carcinoma 88
Can Gemcitabine Instillation Ablate Solitary Low-Risk Non-Muscle-Invasive Bladder Cancer? Results of a Phase II Marker Lesion Study 86
["Classic" vs autolubricant catheterization for endovesicular chemotherapy. Preliminary experience]. 83
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy 83
[Erectile dysfunction in kidney transplanted patients]. 82
Phase II marker lesion study of 6-week intravesical gemcitabine instillation in patients with low risk non muscle invasive bladder tumours 81
KPNA2/ERG Coexpression is Associated with Early Recurrence in Advanced Prostate Cancers 81
CAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancers 80
Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer 79
Evaluation of expression of chromatin assembly factor-1 (CAF-1) p60 in prostatic preneoplastic lesions 79
[Imaging diagnosis of non-lymph node metastasis of bladder carcinoma]. 79
[The Rokitansky-Kuster-Hauser syndrome with chromosome XO/XX mosaicism (single pelvic kidney)]. 79
Cigarette Smoking and Drinking Water Source: Correlation with Clinical Features and Pathology of Superficial Bladder Carcinoma 77
Significance of tumor size in locally advanced renal cell carcinoma (pT3a): An international multicenter experience 76
Prognostic significance of T3A renal cell carcinoma with adrenal gland involvement: An international multicenter experience 76
Zoledronic Acid Increases the Expression of Ndrg1 Gene In Human Androgen-independent Prostate Cancer Pc3 Cells 75
Prostate Health Index (phi) Is Able To Discriminate Benign and Precancerous Conditions From Prostate Cancer 74
Inhibitory Effect of Standardized Cannabis sativa Extract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility 74
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy - A multicenter European study 74
Frequency, clinical presentation and evolution of renal oncocytomas: Multicentric experience from a European database 74
Contemporary Management of Non-muscle Invasive Bladder Cancer At Italian Referral Centres Adopting Eau Guidelines 73
Paclitaxel in Pretreated Metastatic Penile Cancer: Final Results of a Phase 2 Study 73
Gynecomastia due to hormone therapy for advanced prostate cancer: A report of ten surgically treated cases and a review of treatment options 73
Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder Cancer: Update 2016 73
Endovesical Gemcitabine In Recurrent Previously Treated Non-muscle-invasive Bladder Cancer 72
Docetaxel Retreatment In Docetaxel-pretreated Castration-resistant Prostate Cancer 72
Phase II study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer 72
Radiocontrast media cause dephosphorylation of Akt and downstream signaling targets in human renal proximal tubular cells 71
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 70
Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas 68
Effects of the Erbb1/erbb2 Kinase Inhibitor Gw2974 On the Growth and Nse, Chromogranin A and Osteopontin Content of the Androgen-independent Prostate Cancer Cell Line Pc-3 68
Matrix Metalloproteinase-2 And-9 In the Urine of Prostate Cancer Patients 68
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 67
Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading 65
Pca3 Comparison With Prostate Health Index (phi) In Repeat Biopsy Patients 65
Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer 65
Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer 65
Distribution of smoking, water resource and other environmental factors in patients affected by superficial bladder cancer 63
Oral Chemotherapy in Hormone-Refractory Prostate Carcinoma Patients Unwilling to Be Admitted to Hospital 63
Uracyst Enhances the Antitumor Activity of Drugs In Bladder Cancer Cells 62
Efficacy of one-year maintenance in early adjuvant chemotherapy for intermediate risk non-muscle-invasive bladder cancer. Results at 24 months of a randomized trial 62
Npc - A Newer Revolutionary Test For Evaluation of Clinical Series. Bladder Cancer 62
Standard versus hydrophilic catheterization in the adjuvant treatment of patients with superficial bladder cancer 62
Presence of systemic symptoms is the foremost predictor of mortality in patients with exclusive nodal metastases 61
Effects of the antidepressant St. John's wort (hypericum perforatum) on rat and human vas deferens contractility 61
Not traditional prognostic factors in human conventional renal carcinoma. 61
Low-dose oral chemotherapy for hormone refractory prostate carcinoma (HRPC). Estramustine phosphate versus estramustine phosphate and etoposide. A randomised phase II study of GSTU Foundation 60
Out-patient low-dose oral chemotherapy in hormone refractory prostate carcinoma (HRPC) patients unfit for hospital admittance 59
Drinking water source and cigarette smoking in transitional cell carcinoma of the bladder 58
Prevalence of silent prostatic adenocarcinoma in 165 patients undergone cystoprostatectomy: A retrospective study 58
Smoking Status, Recurrence Risk and Intravesical Chemotherapy In Non-muscle-invasive Bladder Cancer 57
Docetaxel and Carboplatin In Docetaxel Pretreated Castraction-resistant Prostate Cancer: Preliminary Results 57
Prognostic impact of tumor size on pT2 renal cell carcinoma: An international multicenter experience 56
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: A phase II study 56
Effects of the ErbB1/ErbB2 kinase inhibitor GW2974 on androgen-independent prostate cancer PC-3 cell line growth and NSE, chromogranin A and osteopontin content 55
Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: A five year follow-up analysis 55
Predictive accuracy of four prognostic models for non-metastatic renal cell carcinoma after nephrectomy: A comparative study. 55
Role of PA2G4P4 pseudogene in bladder cancer tumorigenesis 53
Local hyperthermia for treatment of advanced prostatic carcinoma: preliminary results. 52
Preliminary report of a multicentric study on environmental risk factors in Ta-T1 transitional cell carcinoma of the bladder - A study from Gruppo Studi Tumori Urologici (GSTU) Foundation 51
Ki67 in Gleason Pattern 3 as a Marker of the Presence of Higher-Grade Prostate Cancer 50
Urotensin Ii Receptor Is Involved In the Regulation of Motility of Prostate Adenocarcinoma Cells and Predicts the Clinical Outcome of Prostate Cancer Patients 49
Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the RECORd 2 project) 42
Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients? 40
Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project) 31
Totale 10.657
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.809
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021444 0 0 0 0 88 6 83 3 81 8 89 86
2021/2022566 2 0 1 6 7 8 12 30 94 86 68 252
2022/2023975 95 55 16 114 137 231 0 101 139 0 65 22
2023/2024343 44 68 16 20 30 32 8 36 1 3 8 77
2024/2025783 23 6 20 27 16 183 108 90 90 26 81 113
2025/20263.755 1.393 1.174 727 111 350 0 0 0 0 0 0 0
Totale 10.657